Literature DB >> 9501044

Expression of hemagglutinin/esterase by a mouse hepatitis virus coronavirus defective-interfering RNA alters viral pathogenesis.

X Zhang1, D R Hinton, S Park, B Parra, C L Liao, M M Lai, S A Stohlman.   

Abstract

A defective-interfering (DI) RNA of mouse hepatitis virus (MHV) was developed as a vector for expressing MHV hemagglutinin/esterase (HE) protein. The virus containing an expressed HE protein (A59-DE-HE) was generated by infecting cells with MHV-A59, which does not express HE, and transfecting the in vitro-transcribed DI RNA containing the HE gene. A similar virus (A59-DE-CAT) expressing the chloramphenicol acetyltransferase (CAT) was used as a control. These viruses were inoculated intracerebrally into mice, and the role of the HE protein in viral pathogenesis was evaluated. Results showed that all mice infected with parental A59 or A59-DE-CAT succumbed to infection by 9 days postinfection (p.i.), demonstrating that inclusion of the DI did not by itself alter pathogenesis. In contrast, 60% of mice infected with A59-DE-HE survived infection. HE- or CAT-specific subgenomic mRNAs were detected in the brains at days 1 and 2 p.i. but not later, indicating that the genes in the DI vector were expressed only in the early stage of viral infection. No significant difference in virus titer or viral antigen expression in brains was observed between A59-DE-HE- and A59-DE-CAT-infected mice, suggesting that virus replication in brain was not affected by the expression of HE. However, at day 3 p.i. there was a slight increase in the extent of inflammatory cell infiltration in the brains of the A59-DE-HE-infected mice. Surprisingly, virus titers in the livers of A59-DE-HE-infected mice were 3 log10 lower than that of the A59-DE-CAT-infected mice at day 6 p.i. Also, substantially less necrosis and viral antigen were detected in the livers of the A59-DE-HE-infected mice. This may account for the reduced mortality of these mice. The possible contribution of the host immune system to this difference in pathogenesis was analyzed by comparing the expression of four cytokines. Results showed that both tumor necrosis factor-alpha and interleukin-6 mRNAs increased in the brains of the A59-DE-HE-infected mice at day 2 p.i., whereas interferon-gamma and interleukin-1 alpha mRNAs were similar between A59-DE-HE- and A59-DE-CAT-infected mice. These data suggest that the transient expression of HE protein enhances an early innate immune response, possibly contributing to the eventual clearance of virus from the liver. This study indicates the feasibility of the DI expression system for studying roles of viral proteins during MHV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501044      PMCID: PMC7131006          DOI: 10.1006/viro.1997.8993

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus.

Authors:  K Yokomori; S C Baker; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion.

Authors:  S Makino; M Joo; J K Makino
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis.

Authors:  S A Stohlman; D R Hinton; D Cua; E Dimacali; J Sensintaffar; F M Hofman; S M Tahara; Q Yao
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses.

Authors:  K Yokomori; L R Banner; M M Lai
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

Review 6.  The molecular biology of coronaviruses.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Virus Res       Date:  1983       Impact factor: 9.937

7.  Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus.

Authors:  W Luytjes; P J Bredenbeek; A F Noten; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

8.  Expression of interferon-gamma by a coronavirus defective-interfering RNA vector and its effect on viral replication, spread, and pathogenicity.

Authors:  X Zhang; D R Hinton; D J Cua; S A Stohlman; M M Lai
Journal:  Virology       Date:  1997-07-07       Impact factor: 3.616

9.  Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM).

Authors:  J Joseph; J L Grun; F D Lublin; R L Knobler
Journal:  J Neuroimmunol       Date:  1993-01       Impact factor: 3.478

10.  The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase.

Authors:  H J Lee; C K Shieh; A E Gorbalenya; E V Koonin; N La Monica; J Tuler; A Bagdzhadzhyan; M M Lai
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  18 in total

1.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15.

Authors:  Yinghui Pu; Xuming Zhang
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

3.  Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.

Authors:  Lubna Kazi; Arjen Lissenberg; Richard Watson; Raoul J de Groot; Susan R Weiss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro.

Authors:  A Lissenberg; M M Vrolijk; A L W van Vliet; M A Langereis; J D F de Groot-Mijnes; P J M Rottier; R J de Groot
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection.

Authors:  Rada Popova; Xuming Zhang
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

6.  Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus.

Authors:  A Klausegger; B Strobl; G Regl; A Kaser; W Luytjes; R Vlasak
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase.

Authors:  G Regl; A Kaser; M Iwersen; H Schmid; G Kohla; B Strobl; U Vilas; R Schauer; R Vlasak
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line.

Authors:  P J Koetters; L Hassanieh; S A Stohlman; T Gallagher; M M Lai
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

9.  The spike protein of murine coronavirus regulates viral genome transport from the cell surface to the endoplasmic reticulum during infection.

Authors:  Hongqing Zhu; Dongdong Yu; Xuming Zhang
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

10.  Presence of an encephalomyocarditis virus internal ribosome entry site sequence in avian infectious bronchitis virus defective RNAs abolishes rescue by helper virus.

Authors:  Brian Dove; David Cavanagh; Paul Britton
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.